Abbott (ABT) Tops Q4 EPS by 1c, FY16 EPS Falls Short of Views
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $108.33 -0.42%
EPS Growth %: +9.2%
Financial Fact:
Net Sales: 5.3B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +9.2%
Financial Fact:
Net Sales: 5.3B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $5.2 billion versus the consensus estimate of $5.27 billion.
GUIDANCE:
Abbott sees FY2016 EPS of $2.10-$2.20, versus the consensus of $2.26.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- BlackRock’s Rosenberg says inflation data key after jobs beat
- JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
